FIELD: medicine, pharmaceutics.
SUBSTANCE: offered is the application of hyaluronidase immobilised by electron-beam synthesis nanotechnology as a hypoglycemic agent effective in non-insulin-dependent diabetes mellitus. The mechanism of action is supposed to be modification of the properties of hyaluronic acid of cell glycocalyx and receptors to insulin It is accompanied by higher ligand sensitivity.
EFFECT: in non-insulin-dependent hyperglycemia, immobilised hyaluronidase caused peripheral blood sugar level decreasing by 41,9 %; insulin concentration has been decreasing statistically significantly.
2 tbl
Title | Year | Author | Number |
---|---|---|---|
LIFESPAN INCREASING DRUG | 2011 |
|
RU2461389C1 |
AGENT INTENSIFYING ACTION OF BIOLOGICALLY ACTIVE SUBSTANCES AND DRUGS | 2009 |
|
RU2421239C1 |
DRUG POSSESSING REGENERATIVE ACTIVITY | 2011 |
|
RU2480236C1 |
ANALGESIC | 2011 |
|
RU2452510C1 |
ANTI-INFLAMMATORY AGENT | 2011 |
|
RU2458126C1 |
HEMOSTIMULANT AND EXCITANT AND METHOD FOR HEMOPOIESIS STIMULATION | 2009 |
|
RU2414926C1 |
METHOD OF INCREASING STEM CELLS MOBILIZATION | 2009 |
|
RU2442601C2 |
HEPATOPROTECTOR | 2010 |
|
RU2444569C1 |
AGENT FOR INCREASING RESERVED STEM CELL NUMBER IN ORGANISM | 2009 |
|
RU2405822C1 |
MEDICATION POSSESSING IMMUNOSTIMULATING AND HEMOSTIMULATING ACTION | 2009 |
|
RU2414223C1 |
Authors
Dates
2011-04-20—Published
2009-12-14—Filed